R&D Australia

Servier R&D Australia is the Australian research and development arm of the global pharmaceutical group Servier, focusing on clinical development and translational research. The company operates as a key hub for Servier's global clinical trial network, particularly in the fields of oncology, neuroscience, and immuno-inflammation. By leveraging Australia's robust clinical trial infrastructure and R&D tax incentives, the entity manages early to late-phase clinical programs for a diverse pipeline of small molecules and biologics. Their work is instrumental in advancing therapies for hematological malignancies and neurodegenerative disorders through extensive collaborations with local academic institutions and hospitals.